- Patent Title: Kampo medicine for improving cognitive function in alzheimer-type dementia or mild cognitive impairment and treating at least one disease from the group consisting of overactive bladder, constipation, and chronic kidney diseases complicated by them with one drug
-
Application No.: US16210343Application Date: 2018-12-05
-
Publication No.: US10660929B2Publication Date: 2020-05-26
- Inventor: Yoshiteru Shimoide
- Applicant: Yoshiteru Shimoide
- Agency: Brinks Gilson & Lione
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@40678a8
- Main IPC: A61K36/00
- IPC: A61K36/00 ; A61K36/718 ; A61P25/28 ; A61P1/10 ; A61P13/10 ; A61P13/12 ; A61K36/076 ; A61K36/284 ; A61K36/484 ; A61K36/54 ; A61K36/488 ; A61K36/744 ; A61K36/539 ; A61K36/756

Abstract:
Provided is a kampo medicine for treating multimorbidity of Alzheimer-type dementia or mild cognitive impairment and at least one disease from the group consisting of overactive bladder, constipation, and chronic kidney disease with one drug. A kampo medicine for treating multimorbidity with one drug, comprising a drug combination of orengedokuto and ryokeijutsukanto as an active ingredient, wherein the kampo medicine improves a cognitive function in Alzheimer-type dementia or mild cognitive impairment and relieves and treats at least one disease from overactive bladder, constipation, and chronic kidney disease complicated by Alzheimer-type dementia or mild cognitive impairment at a high rate with one drug.
Public/Granted literature
Information query